Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-15-050145

Director sold 10,000 shares at $6.26 ($62,593)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kraus Al Director 2015-08-13 Option exercise +10,000 $0.88 $8,750 65,746 D
Kraus Al Director 2015-08-13 Sale −10,000 $6.26 $62,593 55,746 D
Derivatives
Kraus Al Director 2015-08-13 Option exercise · Stock Option −10,000 96,773 D
Open-market sales · 10,000 sh · avg $6.26 · $62,593
Loading xslF345X03/v418401_4.xml…